Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons
Clinical trial NCT01218113 · COMPLETED
Trial details
- NCT number
- NCT01218113
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-08
- Primary completion
- 2012-11-05
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.